Amid nationwide injectable Naloxone shortage, Pa. entities rely on Narcan supply
Naloxone, an injectable, intramuscular drug approved by the Food and Drug Administration for the rapid reversal of opioid overdoses, has been in scant supply since Pfizer, the drug’s maker, ran into manufacturing issues in 2020, causing the price of the Naloxone to soar even as demand for the drug increased during pandemic-fueled shutdowns, The Guardian reported earlier this month.
Naloxone can be a lifesaver during opioid overdoses. Why don’t more people carry it? | Opinion
As opioid-related deaths have soared, programs working to get naloxone into the community have increased in response to the need.
Gov. Wolf renews Pa.’s opioid disaster declaration for the sixth time
Gov. Tom Wolf on Friday renewed Pennsylvania’s opioid disaster declaration for the sixth time, giving the state more leeway to combat the addiction crisis. The Democrat signed the first 90-day declaration in January 2018. Since then, according to Wolf’s office, Pennsylvania has: “Removed about 285 tons of prescription drugs from our streets through take-back boxes; […]
Video: Gov. Tom Wolf learns how to administer the overdose-reversal drug naloxone
Wolf demonstrated how simple it is to administer Narcan through a person's (or, on Wednesday, a dummy's) nostril. But there's still a stigma attached to carrying the medication, the governor said.